Haemodynamic support during high-risk percutaneous coronary intervention

Vassili Panagides; Marc Laine; Julien Mancini; Clément Delmas; Melanie Gaubert; Thibaut Dabry; Mourad Boufi; Franck Paganelli; Gilles Lemesle; Laurent Bonello

doi:10.1016/j.acvd.2021.12.002

Haemodynamic support during high-risk percutaneous coronary intervention

Arch Cardiovasc Dis. 2022 Feb;115(2):109-113. doi: 10.1016/j.acvd.2021.12.002. Epub 2022 Jan 31.

Authors

Affiliations

¹ Intensive Care Unit, Hôpital Nord, AP-HM, Aix-Marseille University, 13015 Marseille, France, Mediterranean Association for Research and Studies in Cardiology (MARS Cardio), Centre for CardioVascular and Nutrition Research (C2VN), Inserm 1263, INRA 1260, 13005, Marseille, France.
² Department of Public Health (BIOSTIC), Hôpital de la Timone, Aix-Marseille University, 13005, Marseille, France.
³ Intensive Cardiac Care Unit, Cardiology Department, University Hospital of Rangueil, 31400, Toulouse, France.
⁴ Service de chirurgie vasculaire, Hôpital Nord, AP-HM, 13015, Marseille, France.
⁵ USIC et centre hémodynamique, Institut Cœur Poumon, Centre Hospitalier Universitaire de Lille, 59000, Lille, France.
⁶ Intensive Care Unit, Hôpital Nord, AP-HM, Aix-Marseille University, 13015 Marseille, France, Mediterranean Association for Research and Studies in Cardiology (MARS Cardio), Centre for CardioVascular and Nutrition Research (C2VN), Inserm 1263, INRA 1260, 13005, Marseille, France. Electronic address: laurent.bonello@ap-hm.fr.

PMID: 35115264
DOI: 10.1016/j.acvd.2021.12.002

No abstract available

Keywords: Angioplasties à très haut risque; Haemodynamic impairment; High-risk percutaneous intervention; Impella; Impella®; Instabilité hémodynamique; Mechanical assist device; Système d’assistance mécanique.

Publication types

Letter

MeSH terms

Heart-Assist Devices*
Hemodynamics
Humans
Percutaneous Coronary Intervention* / adverse effects
Shock, Cardiogenic
Treatment Outcome